Memantine and Incident Atrial Fibrillation or Flutter in Alzheimer's Disease: A Propensity Score-Matched Analysis

JACC Clin Electrophysiol. 2024 Jun;10(6):1197-1199. doi: 10.1016/j.jacep.2024.03.028. Epub 2024 Apr 5.

Authors

Bharat Rawlley¹, Kartik Gupta², Subaina Naeem Khalid¹, Pratyaksh P Vaishnav¹, Andres Cordova Sanchez³, Alexander Somerville¹, Anderson Anuforo¹, Sonal Pruthi⁴, Debanik Chaudhuri⁵

Affiliations

¹ State University of New York Upstate Medical University, Syracuse, New York, USA.
² Henry Ford Hospital, Detroit, Michigan, USA.
³ University of Vermont Medical Center, Burlington, Vermont, USA.
⁴ Columbia University Irving Medical Center, New York, USA.
⁵ State University of New York Upstate Medical University, Syracuse, New York, USA. Electronic address: [email protected].

PMID: 38727659
DOI: 10.1016/j.jacep.2024.03.028

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Alzheimer Disease* / drug therapy
Antiparkinson Agents* / adverse effects
Antiparkinson Agents* / therapeutic use
Atrial Flutter / epidemiology
Atrial Flutter / prevention & control
Female
Humans
Incidence
Male
Memantine* / adverse effects
Memantine* / therapeutic use
Propensity Score

Substances

Memantine
Antiparkinson Agents